Balyasny Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-614,682
| Closed | -$11.2M | – | 2124 |
|
|
2024
Q3 | $11.2M | Buy |
+614,682
| New | +$11.2M | 0.02% | 628 |
|
|
2024
Q2 | – | Sell |
-208,681
| Closed | -$7.4M | – | 2146 |
|
|
2024
Q1 | $7.4M | Buy |
208,681
+163,982
| +367% | +$5.81M | 0.01% | 770 |
|
|
2023
Q4 | $1.95M | Buy |
44,699
+14,583
| +48% | +$635K | ﹤0.01% | 1038 |
|
|
2023
Q3 | $1.15M | Sell |
30,116
-215,455
| -88% | -$8.23M | ﹤0.01% | 1126 |
|
|
2023
Q2 | $10.1M | Buy |
245,571
+163,649
| +200% | +$6.73M | 0.02% | 600 |
|
|
2023
Q1 | $4.7M | Buy |
81,922
+49,386
| +152% | +$2.84M | 0.01% | 819 |
|
|
2022
Q4 | $1.82M | Sell |
32,536
-179,540
| -85% | -$10.1M | 0.01% | 1095 |
|
|
2022
Q3 | $8.98M | Buy |
+212,076
| New | +$8.98M | 0.03% | 581 |
|
|
2021
Q2 | – | Sell |
-79,423
| Closed | -$5.49M | – | 1844 |
|
|
2021
Q1 | $5.49M | Buy |
+79,423
| New | +$5.49M | 0.03% | 553 |
|
|
2019
Q3 | – | Sell |
-32,841
| Closed | -$1.83M | – | 1209 |
|
|
2019
Q2 | $1.83M | Buy |
32,841
+11,577
| +54% | +$647K | 0.01% | 762 |
|
|
2019
Q1 | $1.19M | Buy |
+21,264
| New | +$1.19M | 0.01% | 866 |
|
|
2018
Q3 | – | Sell |
-3,489
| Closed | -$225K | – | 1583 |
|
|
2018
Q2 | $225K | Buy |
+3,489
| New | +$225K | ﹤0.01% | 1428 |
|
|
2015
Q3 | – | Sell |
-8,147
| Closed | -$224K | – | 1064 |
|
|
2015
Q2 | $224K | Buy |
+8,147
| New | +$224K | ﹤0.01% | 767 |
|